Certain Ordinary Shares of Virax Biolabs Group Limited are subject to a Lock-Up Agreement Ending on 21-JUL-2023.
Details:
Directors, and certain holders of company's ordinary shares have agreed with the underwriters not to offer for sale, issue, sell, contract to sell, pledge, or otherwise dispose of any of company's ordinary shares or securities convertible into ordinary shares for a period of twelve (12) months from the date on which the trading of the ordinary shares on a National Securities Exchange commences.